Back to search

Economic analyses of toxicity secondary to anthracycline-based breast cancer chemotherapy

Data up to Jan 2025

Published1995
Citations19
References20

Total Citations Per Year

Abstract

References (20)

Principles and Practice of Infectious Diseases.

1991 • 12,590 citations

Confidence intervals rather than P values: estimation rather than hypothesis testing.

1986 • 1,947 citations

Users' Guides to the Medical Literature

1993 • 943 citations

Users' guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid? Evidence-Based Medicine Working Group

1993 • 824 citations

Economic impact of heart failure in the United States: time for a different approach.

1994 • 669 citations

Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy

1987 • 501 citations

Origin of Infection in Acute Nonlymphocytic Leukemia

1972 • 501 citations

A prospective randomized comparison of epirubicin and doxorubicin in patients with advanced breast cancer.

1985 • 247 citations

Cancer Statistics, 1987

1987 • 241 citations

A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy

1978 • 236 citations

Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsy.

1986 • 201 citations

Epirubicin and doxorubicin: a comparison of their characteristics, therapeutic activity and toxicity

1993 • 196 citations

A prospective randomized phase III trial comparing combination chemotherapy with cyclophosphamide, fluorouracil, and either doxorubicin or epirubicin. French Epirubicin Study Group.

1988 • 176 citations

Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial. Italian Multicentre Breast Study with Epirubicin.

1988 • 167 citations

Chemotherapy versus chemoimmunotherapy (CAF v CAFVP v CMF each +/- MER) for metastatic carcinoma of the breast: a CALGB study. Cancer and Leukemia Group B.

1987 • 124 citations

Epirubicin at two dose levels with prednisolone as treatment for advanced breast cancer: the results of a randomized trial.

1991 • 118 citations

Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCG

1979 • 78 citations

The Costs of Treating Febrile Neutropenia in Patients with Malignant Blood Disorders

1994 • 27 citations

Incidence and Cost of Hospital Admissions Secondary to Drug Interactions Involving Theophylline

1992 • 25 citations

1992 Canadian Cancer Statistics.

1992 • 17 citations

Cited By (0)

No citing papers found in database

Economic analyses of toxicity secondary to anthracycline-based breast cancer chemotherapy (1995) – European Journal of Cancer | Metascience Observatory Explorer